Výsledky vyhledávání - Marc Ditmarsch
- Zobrazuji výsledky 1 - 8 z 8
-
1
-
2
-
3
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial Autor Stephen J. Nicholls, Marc Ditmarsch, John J.P. Kastelein, Scott P. Rigby, Douglas Kling, Danielle Curcio, Nicholas John, Michael H. Davidson
Vydáno 2022Artigo -
4
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels Autor Adam J. Nelson, Allan D. Sniderman, Marc Ditmarsch, Mary R. Dicklin, Stephen J. Nicholls, Michael H. Davidson, John J.P. Kastelein
Vydáno 2022Revisão -
5
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial Autor Christie M. Ballantyne, Marc Ditmarsch, John J.P. Kastelein, Adam J. Nelson, Douglas Kling, Andrew Hsieh, Danielle Curcio, Kevin C. Maki, Michael H. Davidson, Stephen J. Nicholls
Vydáno 2023Artigo -
6
Obicetrapib as an Adjunct to Stable Statin Therapy in Japanese Subjects: Results from a Randomized Phase 2 Trial Autor Mariko Harada‐Shiba, Michael H. Davdison, Marc Ditmarsch, Andrew Hsieh, Erin Wuerdeman, Douglas Kling, A. Nield, Mary R. Dicklin, Akitaka Nakata, Atsushi Sueyoshi, Satoshi Kuroyanagi, John J.P. Kastelein
Vydáno 2024Artigo -
7
The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial Autor Kausik K. Ray, Marc Ditmarsch, David Kallend, Eric J. Niesor, Gabriela Suchánková, Ruchi Upmanyu, Judith Anzures‐Cabrera, Valerie Lehnert, Meike Pauly-Evers, Ingar Holme, Josef Šťásek, M. W. J. van Hessen, Peter J.H. Jones
Vydáno 2014Artigo -
8
Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADW... Autor Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Návar, Steven E. Nissen, Anne C. Golberg, Liam R. Brunham, Danielle Curcio, Erin Wuerdeman, Annie Neild, Douglas Kling, Andrew Hsieh, Mary R. Dicklin, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Michael H. Davidson
Vydáno 2024Artigo
Vyhledávací nástroje:
Související témata
Apolipoprotein B
Cholesterol
Cholesterylester transfer protein
Endocrinology
Internal medicine
Lipoprotein
Medicine
Pharmacology
Ezetimibe
Adverse effect
Alternative medicine
Pathology
Placebo
Tolerability
Gastroenterology
LDL receptor
PCSK9
Randomized controlled trial
Statin
Biochemistry
Chemistry
Dyslipidemia
Environmental health
Gene
Population
ABCA1
Acute coronary syndrome
Atorvastatin
Biology
Clinical endpoint